Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin.

Orlando F, Paolini C, Agarbati S, Tonnini C, Grieco A, Capelli C, Introna M, Provinciali M, Gabrielli A, Moroncini G.

J Vis Exp. 2019 Apr 30;(146). doi: 10.3791/58922.

PMID:
31107440
2.

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2019 Jan;18(1):93-106. doi: 10.1016/j.autrev.2018.08.003. Epub 2018 Nov 5. Review.

PMID:
30408582
3.

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice.

Moroncini G, Paolini C, Orlando F, Capelli C, Grieco A, Tonnini C, Agarbati S, Mondini E, Saccomanno S, Goteri G, Svegliati Baroni S, Provinciali M, Introna M, Del Papa N, Gabrielli A.

PLoS One. 2018 Jun 1;13(6):e0196048. doi: 10.1371/journal.pone.0196048. eCollection 2018.

4.

Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis.

Moroncini G, Benfaremo D, Mandolesi A, Gabrielli A.

BMJ Case Rep. 2018 May 18;2018. pii: bcr-2018-224829. doi: 10.1136/bcr-2018-224829.

PMID:
29776943
5.

NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis.

Svegliati S, Spadoni T, Moroncini G, Gabrielli A.

Free Radic Biol Med. 2018 Sep;125:90-97. doi: 10.1016/j.freeradbiomed.2018.04.554. Epub 2018 Apr 22. Review.

PMID:
29694853
6.

Developments in the management of advanced soft-tissue sarcoma - olaratumab in context.

Moroncini G, Maccaroni E, Fiordoliva I, Pellei C, Gabrielli A, Berardi R.

Onco Targets Ther. 2018 Feb 16;11:833-842. doi: 10.2147/OTT.S127609. eCollection 2018. Review.

7.

Biologics in Inflammatory Immune-mediated Systemic Diseases.

Moroncini G, Calogera G, Benfaremo D, Gabrielli A.

Curr Pharm Biotechnol. 2017;18(12):1008-1016. doi: 10.2174/1389201019666171226152448. Review.

PMID:
29278213
8.

Agonistic antibodies in systemic sclerosis.

Moroncini G, Svegliati Baroni S, Gabrielli A.

Immunol Lett. 2018 Mar;195:83-87. doi: 10.1016/j.imlet.2017.10.007. Epub 2017 Oct 13. Review.

PMID:
29032187
9.

Reply.

Luchetti MM, Moroncini G, Svegliati S, Larcher F, Avvedimento EV, Gabrielli A.

Arthritis Rheumatol. 2017 Aug;69(8):1703-1704. doi: 10.1002/art.40138. Epub 2017 Jun 14. No abstract available.

10.

Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.

Moroncini G, Cuccioloni M, Mozzicafreddo M, Pozniak KN, Grieco A, Paolini C, Tonnini C, Spadoni T, Svegliati S, Funaro A, Angeletti M, Gabrielli A.

Anal Biochem. 2017 Jul 1;528:26-33. doi: 10.1016/j.ab.2017.04.011. Epub 2017 Apr 24.

PMID:
28450104
11.

Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress.

Mori S, Sugama S, Nguyen W, Michel T, Sanna MG, Sanchez-Alavez M, Cintron-Colon R, Moroncini G, Kakinuma Y, Maher P, Conti B.

J Neuroinflammation. 2017 Apr 21;14(1):88. doi: 10.1186/s12974-017-0862-1.

12.

Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.

Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, Paolini C, Tonnini C, Grieco A, Rovinelli M, Funaro A, Gabrielli A.

Front Immunol. 2017 Apr 12;8:381. doi: 10.3389/fimmu.2017.00381. eCollection 2017.

13.

Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro.

Svegliati S, Amico D, Spadoni T, Fischetti C, Finke D, Moroncini G, Paolini C, Tonnini C, Grieco A, Rovinelli M, Funaro A, Gabrielli A.

Front Immunol. 2017 Feb 8;8:75. doi: 10.3389/fimmu.2017.00075. eCollection 2017. Erratum in: Front Immunol. 2017 Apr 12;8:381.

14.

Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort.

López-Isac E, Bossini-Castillo L, Palma AB, Assassi S, Mayes MD, Simeón CP, Ortego-Centeno N, Vicente E, Tolosa C, Rubio-Rivas M, Román-Ivorra JA, Beretta L, Moroncini G, Hunzelmann N, Distler JHW, Riemekasten G, de Vries-Bouwstra J, Voskuyl AE, Radstake TRDJ, Herrick A, Denton CP, Fonseca C, Martín J.

Arthritis Rheumatol. 2017 Jun;69(6):1337-1338. doi: 10.1002/art.40058. Epub 2017 May 9. No abstract available.

15.

The Proinflammatory Cytokine Interleukin 18 Regulates Feeding by Acting on the Bed Nucleus of the Stria Terminalis.

Francesconi W, Sánchez-Alavez M, Berton F, Alboni S, Benatti C, Mori S, Nguyen W, Zorrilla E, Moroncini G, Tascedda F, Conti B.

J Neurosci. 2016 May 4;36(18):5170-80. doi: 10.1523/JNEUROSCI.3919-15.2016.

16.

Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.

López-Isac E, Martín JE, Assassi S, Simeón CP, Carreira P, Ortego-Centeno N, Freire M, Beltrán E, Narváez J, Alegre-Sancho JJ; Spanish Scleroderma Group, Fernández-Gutiérrez B, Balsa A, Ortiz AM, González-Gay MA, Beretta L, Santaniello A, Bellocchi C, Lunardi C, Moroncini G, Gabrielli A, Witte T, Hunzelmann N, Distler JH, Riekemasten G, van der Helm-van Mil AH, de Vries-Bouwstra J, Magro-Checa C, Voskuyl AE, Vonk MC, Molberg Ø, Merriman T, Hesselstrand R, Nordin A, Padyukov L, Herrick A, Eyre S, Koeleman BP, Denton CP, Fonseca C, Radstake TR, Worthington J, Mayes MD, Martín J.

Arthritis Rheumatol. 2016 Sep;68(9):2338-44. doi: 10.1002/art.39730.

17.

Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies.

Luchetti MM, Moroncini G, Jose Escamez M, Svegliati Baroni S, Spadoni T, Grieco A, Paolini C, Funaro A, Avvedimento EV, Larcher F, Del Rio M, Gabrielli A.

Arthritis Rheumatol. 2016 Sep;68(9):2263-73. doi: 10.1002/art.39728.

18.

Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile.

Moroncini G, Albani L, Nobili L, Gabrielli A.

Curr Drug Saf. 2016;11(1):44-6. Review.

PMID:
26463247
19.

Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.

Fraticelli P, De Vita S, Franzolini N, Svegliati S, Scott CA, Tonnini C, Spadoni T, Gabrielli B, Pomponio G, Moroncini G, Gabrielli A.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S160-7. Epub 2015 Sep 1.

PMID:
26339895
20.

Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway.

López-Isac E, Campillo-Davo D, Bossini-Castillo L, Guerra SG, Assassi S, Simeón CP, Carreira P, Ortego-Centeno N, García de la Peña P; Spanish Scleroderma Group, Beretta L, Santaniello A, Bellocchi C, Lunardi C, Moroncini G, Gabrielli A, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Distler JH, Voskuyl AE, de Vries-Bouwstra J, Herrick A, Worthington J, Denton CP, Fonseca C, Radstake TR, Mayes MD, Martín J.

Ann Rheum Dis. 2016 Aug;75(8):1521-6. doi: 10.1136/annrheumdis-2015-208154. Epub 2015 Sep 2.

21.

Monoacylglycerol Lipase Regulates Fever Response.

Sanchez-Alavez M, Nguyen W, Mori S, Moroncini G, Viader A, Nomura DK, Cravatt BF, Conti B.

PLoS One. 2015 Aug 19;10(8):e0134437. doi: 10.1371/journal.pone.0134437. eCollection 2015.

22.

Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?'.

Iudici M, Moroncini G, Cipriani P, Giacomelli R, Gabrielli A, Valentini G.

Autoimmun Rev. 2016 Feb;15(2):202. doi: 10.1016/j.autrev.2015.06.007. Epub 2015 Jun 26. No abstract available.

PMID:
26123179
23.

Reply to J. Magalon et al.

Del Papa N, Di Luca G, Sambataro D, Zaccara E, Maglione W, Gabrielli A, Fraticelli P, Moroncini G, Beretta L, Santaniello A, Sambataro G, Ferraresi R, Vitali C.

Cell Transplant. 2015;24(12):2669-70. doi: 10.3727/096368915X688218. Epub 2015 May 20. No abstract available.

PMID:
25995101
24.

Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.

Moroncini G, Grieco A, Nacci G, Paolini C, Tonnini C, Pozniak KN, Cuccioloni M, Mozzicafreddo M, Svegliati S, Angeletti M, Kazlauskas A, Avvedimento EV, Funaro A, Gabrielli A.

Arthritis Rheumatol. 2015 Jul;67(7):1891-903. doi: 10.1002/art.39125.

25.

Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?

Iudici M, Moroncini G, Cipriani P, Giacomelli R, Gabrielli A, Valentini G.

Autoimmun Rev. 2015 Jul;14(7):575-8. doi: 10.1016/j.autrev.2015.02.002. Epub 2015 Feb 21. Review.

PMID:
25709096
26.

A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis.

Spadoni T, Svegliati Baroni S, Amico D, Albani L, Moroncini G, Avvedimento EV, Gabrielli A.

Arthritis Rheumatol. 2015 Jun;67(6):1611-22. doi: 10.1002/art.39084.

27.

Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis.

Del Papa N, Di Luca G, Sambataro D, Zaccara E, Maglione W, Gabrielli A, Fraticelli P, Moroncini G, Beretta L, Santaniello A, Sambataro G, Ferraresi R, Vitali C.

Cell Transplant. 2015;24(11):2297-305. doi: 10.3727/096368914X685636. Epub 2014 Dec 12.

PMID:
25506730
28.

Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis.

Svegliati S, Marrone G, Pezone A, Spadoni T, Grieco A, Moroncini G, Grieco D, Vinciguerra M, Agnese S, Jüngel A, Distler O, Musti AM, Gabrielli A, Avvedimento EV.

Sci Signal. 2014 Sep 2;7(341):ra84. doi: 10.1126/scisignal.2004592.

PMID:
25185156
29.

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.

Fraticelli P, Gabrielli B, Pomponio G, Valentini G, Bosello S, Riboldi P, Gerosa M, Faggioli P, Giacomelli R, Del Papa N, Gerli R, Lunardi C, Bombardieri S, Malorni W, Corvetta A, Moroncini G, Gabrielli A; Imatinib in Scleroderma Italian Study Group.

Arthritis Res Ther. 2014 Jul 8;16(4):R144. doi: 10.1186/ar4606.

30.

Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance.

Schicchi N, Valeri G, Moroncini G, Agliata G, Salvolini L, Gabrielli A, Giovagnoni A.

Radiol Med. 2014 Dec;119(12):885-894. doi: 10.1007/s11547-014-0419-7. Epub 2014 Jun 7. Erratum in: Radiol Med. 2014 Dec;119(12):958. Pomponio, Giovanni [added]; Dziadzio, Magdalena [added]; della Costanza, Osmy Paci [added]; Pierfederici, Alessandra [added]; Ferretti, Lorenzo [added]; Pupita, Giuseppe [added].

PMID:
24907065
31.

Role of viral infections in the etiopathogenesis of systemic sclerosis.

Moroncini G, Mori S, Tonnini C, Gabrielli A.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):3-7. Epub 2013 Jul 22. Review.

PMID:
23910606
32.

New insights into the role of oxidative stress in scleroderma fibrosis.

Gabrielli A, Svegliati S, Moroncini G, Amico D.

Open Rheumatol J. 2012;6:87-95. doi: 10.2174/1874312901206010087. Epub 2012 Jun 15.

33.

Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin.

Dubins JS, Sanchez-Alavez M, Zhukov V, Sanchez-Gonzalez A, Moroncini G, Carvajal-Gonzalez S, Hadcock JR, Bartfai T, Conti B.

Metabolism. 2012 Oct;61(10):1486-93. doi: 10.1016/j.metabol.2012.03.015. Epub 2012 May 4.

34.

Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts.

Smaldone S, Olivieri J, Gusella GL, Moroncini G, Gabrielli A, Ramirez F.

Fibrogenesis Tissue Repair. 2011 Mar 1;4(1):8. doi: 10.1186/1755-1536-4-8.

35.

Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al.

Gabrielli A, Moroncini G, Svegliati S, Avvedimento EV.

Arthritis Rheum. 2009 Nov;60(11):3521-2. doi: 10.1002/art.27209. No abstract available.

36.

Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies.

Martucci F, Acutis P, Mazza M, Nodari S, Colussi S, Corona C, Barocci S, Gabrielli A, Caramelli M, Casalone C, Moroncini G.

J Gen Virol. 2009 Apr;90(Pt 4):1048-53. doi: 10.1099/vir.2008.007120-0. Epub 2009 Feb 17.

PMID:
19223486
37.

Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction.

Montironi R, Cheng L, Mazzucchelli R, Morichetti D, Stramazzotti D, Santinelli A, Moroncini G, Galosi AB, Muzzonigro G, Comeri G, Lovisolo J, Cosciani-Cunico S, Bono AV.

Cell Oncol. 2008;30(6):473-82.

38.

Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice.

Sanchez-Alavez M, Criado JR, Klein I, Moroncini G, Conti B.

Neuroreport. 2008 Oct 8;19(15):1473-7. doi: 10.1097/WNR.0b013e32830f1e90.

39.

Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited.

Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV.

Semin Immunopathol. 2008 Jul;30(3):329-37. doi: 10.1007/s00281-008-0125-4. Epub 2008 Jun 12. Review.

PMID:
18548250
40.

Pathogenic autoantibodies in systemic sclerosis.

Gabrielli A, Svegliati S, Moroncini G, Avvedimento EV.

Curr Opin Immunol. 2007 Dec;19(6):640-5. Review.

PMID:
18083509
41.

Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.

Gabrielli A, Svegliati S, Moroncini G, Luchetti M, Tonnini C, Avvedimento EV.

Autoimmun Rev. 2007 Dec;7(2):121-6. Epub 2007 Mar 28. Review.

PMID:
18035321
42.

Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation.

Sánchez-Alavez M, Conti B, Moroncini G, Criado JR.

Brain Res. 2007 Jul 16;1158:71-80. Epub 2007 May 22.

43.

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.

Svegliati S, Olivieri A, Campelli N, Luchetti M, Poloni A, Trappolini S, Moroncini G, Bacigalupo A, Leoni P, Avvedimento EV, Gabrielli A.

Blood. 2007 Jul 1;110(1):237-41. Epub 2007 Mar 15.

44.

Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.

Moroncini G, Mangieri M, Morbin M, Mazzoleni G, Ghetti B, Gabrielli A, Williamson RA, Giaccone G, Tagliavini F.

Neurobiol Dis. 2006 Sep;23(3):717-24. Epub 2006 Jul 28.

PMID:
16876426
45.

Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.

Moroncini G, Kanu N, Solforosi L, Abalos G, Telling GC, Head M, Ironside J, Brockes JP, Burton DR, Williamson RA.

Proc Natl Acad Sci U S A. 2004 Jul 13;101(28):10404-9. Epub 2004 Jul 6.

46.

Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.

Burioni R, Bugli F, Mancini N, Rosa D, Di Campli C, Moroncini G, Manzin A, Abrignani S, Varaldo PE, Clementi M, Fadda G.

Virology. 2001 Sep 15;288(1):29-35.

Supplemental Content

Loading ...
Support Center